Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Stopped NIH terminated funding. Study was closed before any participants were enrolled.

Conditions

• Plasma Cell Myeloma

Interventions

• BIOLOGICAL: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
• DRUG: Melphalan
• PROCEDURE: Peripheral Blood Stem Cell Transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

• [object Object]
• [object Object]